75N93018D00013↗
Battelle Memorial Institute received this contract vehicle from National Institutes of Health Niaid, National Institutes of Health: $0 obligated so far for health r&d services; health care services; applied research. It runs to 2028-09-11.
Key facts · data as of Oct 26, 2026
- Recipient
- Battelle Memorial Institute
- Awarding agency
- National Institutes of Health (Department of Health and Human Services)
- Contracting office
- National Institutes of Health Niaid (75N930)
- Obligated to date
- $0
- Potential value
- $112.00M
- Ends
- 2028-09-11
Source: USAspending.gov prime award records (obligations: money committed, not outlays), data as of Oct 26, 2026.
Cite this page: SpendQuery, Award 75N93018D00013, data as of Oct 26, 2026, https://spendquery.com/award?id=CONT_IDV_75N93018D00013_7529
Battelle Memorial Institute: all federal awards · Department of Health and Human Services: spending · National Institutes of Health Niaid: what it buys · The follow-on: recompete brief
EVALUATION AND TESTING SERVICES (ETS) FOR VACCINES AND OTHER BIOLOGICS FOR INFECTIOUS DISEASES
Up for re-bid: ends 2028-09-11. Recompete brief →
What it is
- Product or service
- Health R&D Services; Health Care Services; Applied Research (PSC AN12)
- Industry
- Research and Development in Nanotechnology (NAICS 541713)
- Contracting office
- National Institutes of Health Niaid (75N930)
- Competition
- Full and open competition · 2 offers received
- Pricing
- Cost plus fixed fee
- How it was bought
- Contract vehicle (IDV) itself
- Solicitation
- NIAIDDMIDNIHAI2017087
Obligations by fiscal year
SpendQuery holds FY2023 on; earlier years are on USAspending.gov.
Subcontractors: where the money went next
No subawards reported for this award. Primes report subawards of $30,000 or more; many awards have none.
Orders under this vehicle
17 orders worth $46.05M (current value). The largest:
- 75N93019F00131 · $11.52M · ends 2028-05-31
- 75N93021F00002 · $11.30M · ends 2026-12-31
- 75N93020F00006 · $6.40M · ends 2025-04-17
- 75N93022F00004 · $3.83M · ends 2026-12-31
- 75N93022F00005 · $2.85M · ends 2025-04-17
- 75N93024F00001 · $2.37M · ends 2026-09-05
- 75N93020F00001 · $1.48M · ends 2023-06-30
- 75N93023F00002 · $1.09M · ends 2025-04-17
- 75N93018F00001 · $869.9K · ends 2025-04-17
- 75N93022F00002 · $843.9K · ends 2025-11-30
- 75N93023F00001 · $657.9K · ends 2025-10-31
- 75N93022F00003 · $656.2K · ends 2024-10-31
- 75N93020F00005 · $634.7K · ends 2021-12-31
- 75N93019F00366 · $612.8K · ends 2021-09-30
- 75N93020F00004 · $435.8K · ends 2023-02-26
- 75N93021F00001 · $305.4K · ends 2024-04-30
- 75N93022F00001 · $203.3K · ends 2023-05-31
Every action
4 actions since 2022-12-14. Each is a modification or amendment with the money it added or took back.
| Date | Modification | Kind | Amount | What the agency wrote |
|---|---|---|---|---|
| 2025-03-06 | P00016 | Supplemental agreement (work within scope) | $0 | EVALUATION AND TESTING SERVICES (ETS) FOR VACCINES AND OTHER BIOLOGICS FOR INFECTIOUS DISEASES |
| 2024-10-24 | P00015 | Supplemental agreement (work within scope) | $0 | EVALUATION AND TESTING SERVICES (ETS) FOR VACCINES AND OTHER BIOLOGICS FOR INFECTIOUS DISEASES |
| 2023-09-20 | P00014 | Supplemental agreement (work within scope) | $0 | EVALUATION AND TESTING SERVICES (ETS) FOR VACCINES AND OTHER BIOLOGICS FOR INFECTIOUS DISEASES |
| 2022-12-14 | P00013 | Supplemental agreement (work within scope) | $0 | EVALUATION AND TESTING SERVICES (ETS) FOR VACCINES AND OTHER BIOLOGICS FOR INFECTIOUS DISEASES |
Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-26). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗